ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EWTX Edgewise Therapeutics Inc

17.36
-0.82 (-4.51%)
Last Updated: 14:30:06
Delayed by 15 minutes

Period:

Draw Mode:

Volume 234,273
Bid Price 17.33
Ask Price 17.37
News -
Day High 18.36

Low
5.12

52 Week Range

High
21.60

Day Low 17.36
Company Name Stock Ticker Symbol Market Type
Edgewise Therapeutics Inc EWTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.82 -4.51% 17.36 14:30:06
Open Price Low Price High Price Close Price Prev Close
18.18 17.36 18.36 18.18
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,530 234,273 $ 17.70 $ 4,145,693 - 5.12 - 21.60
Last Trade Time Type Quantity Stock Price Currency
14:32:46 4 $ 17.3494 USD

Edgewise Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.63B 93.11M - 0 -100.16M -1.08 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Edgewise Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EWTX Message Board. Create One! See More Posts on EWTX Message Board See More Message Board Posts

Historical EWTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week17.6618.8917.2218.17601,464-0.30-1.70%
1 Month15.6621.6015.0818.53744,5401.7010.86%
3 Months16.9921.6014.9017.36728,0460.372.18%
6 Months6.4321.605.9314.66852,61410.93169.98%
1 Year9.6321.605.1213.19522,6637.7380.27%
3 Years28.4329.755.1213.09328,718-11.07-38.94%
5 Years27.0040.495.1213.58321,706-9.64-35.70%

Edgewise Therapeutics Description

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.

Your Recent History

Delayed Upgrade Clock